MatriSys Bioscience, Inc.
Biotechnology ResearchCalifornia, United States2-10 Employees
MatriSys Bioscience, Inc. is a clinical-stage specialty biopharmaceutical company based in La Jolla, California, focused on the dermatology and skin care space. It develops microbiome-based therapies that apply beneficial skin bacteria to rebalance the native microbiome and selectively suppress pathogenic organisms. The company pursues treatments for five principal dermatology conditions—Atopic Dermatitis, Rosacea, Psoriasis, Acne, and Skin Infections—aiming to address outcomes that significantly affect patients' quality of life. Its lead program is in Phase I/II and centers on Atopic Dermatitis, with a patient population estimated at 15 million in the United States and 132 million worldwide. The initiative is NIH-funded and protected by an exclusive license from the University of California, San Diego, and uses Staphylococcus hominis to target Staphylococcus aureus while preserving other beneficial microbes. In 2021, MatriSys expanded its licensing arrangement with UCSD School of Medicine related to Acne treatment (MSB-3163), reflecting ongoing collaboration with academic partners.
1-888-653-2347 
support@leadiq.com 
